The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major advancement in schizophrenia treatment in decades.
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
ETX Daily Up on MSN13h
New drug for schizophrenics has experts excitedNew drug for schizophrenics has experts excited Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. "This drug takes ...
While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?
Benzinga (Video) on MSN3d
FDA Approves First Novel Schizophrenia Drug in 70 Years, Impacting Up to 3 Million Patients in the USThe FDA has approved Bristol Myers Squibb’s new schizophrenia drug, Cobenfy, the first novel treatment for schizophrenia in over 70 years. Schizophrenia affects nearly 3 million U.S. adults, but only ...
None of those who experienced nausea reduced their doses or stopped taking Terns’ pill, though, and all completed treatment. A 500-milligram dose of TERN-601 also led to statistically significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback